SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: MarcG who wrote (37)11/12/1997 11:09:00 PM
From: Gerald Underwood  Read Replies (1) of 857
 
Marc,

Interesting bit of news turned up in HEB 10Q just released for qtr ending 9/30. Under recent developments, it seems that HEB made
two private placements of ttl 4,840,000 shrs for $10,005.000. in October 97. Ever wonder what happened to the stock price during October? However, in spite of this dilution, stock price still
shows remarkable strength even during general market paranoia and company selling off stock for half price.

Biotechs are taking some hits.

Regards,

Gerry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News